NCT05484258

Brief Summary

The high need population are patients who have three or more chronic diseases and have a functional limitation in their ability to take care for themselves. Investigators aim to understand the effects of a support group intervention, with the use of group medical visits and understand longitudinal effects in emotional wellbeing and loneliness.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
23

participants targeted

Target at below P25 for not_applicable anxiety

Timeline
Completed

Started Aug 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 27, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 2, 2022

Completed
13 days until next milestone

Study Start

First participant enrolled

August 15, 2022

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2023

Completed
Last Updated

September 6, 2023

Status Verified

September 1, 2023

Enrollment Period

11 months

First QC Date

July 27, 2022

Last Update Submit

September 5, 2023

Conditions

Keywords

high need populationshared medical visitssocial determinants of health

Outcome Measures

Primary Outcomes (1)

  • Change in Loneliness from Baseline at 0 and at 3, 6 and 9 months.

    Using the Validated De Jong Giervald Loneliness Scale, scored from 0 (not lonely) to 11 (severely lonely),

    0, 3, 6, and 9 months

Secondary Outcomes (3)

  • Change in the number of ED visits, Inpatient, Observations

    0, 3, 6 and 9 months

  • Change in Depression from Baseline (0), and at 3, 6, and 9 months

    0, 3,6, and 9 months

  • Change in Active alcohol use disorders (including alcohol abuse or dependence) from Baseline (0), and at 3, 6, and 9 months

    0,3,6, and 9 months

Study Arms (2)

Standard Care

NO INTERVENTION

On baseline screen, would be screened for depression, alcohol use, and loneliness. Loneliness screen will be checked every 3 months.

Group Medical VIsits

ACTIVE COMPARATOR

For this arm, patients will have three visits of a shared medical visit, wherein a physician/APP will partner with a social worker to give a discussion about topics relevant to the high need population, including managing multiple medications, managing stress, and also palliative care.

Behavioral: Shared Medical Visit

Interventions

Group visit wherein physician and Social Worker, would be discussing topics relevant to the population.

Group Medical VIsits

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who are enrolled into the VIC program. These are patients that are 18 years old and above, and have either
  • HCC Score 3.0 and above
  • HCC 2.0 - 3.0 and 2 or more unplanned admissions in last 12 months
  • HCC 0.24 - 0.35 + ESRD OR
  • Charlson Score \>3, or LACE \>30

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vanderbilt University Medical Center

Nashville, Tennessee, 37203, United States

Location

MeSH Terms

Conditions

Anxiety DisordersDepressionAlcoholismPatient Acceptance of Health Care

Condition Hierarchy (Ancestors)

Mental DisordersBehavioral SymptomsBehaviorAlcohol-Related DisordersSubstance-Related DisordersChemically-Induced DisordersTreatment Adherence and ComplianceHealth Behavior

Study Officials

  • FRANCIS S BALUCAN

    Vanderbilt University Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Director

Study Record Dates

First Submitted

July 27, 2022

First Posted

August 2, 2022

Study Start

August 15, 2022

Primary Completion

June 30, 2023

Study Completion

September 1, 2023

Last Updated

September 6, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
July 2023 available for 1 year

Locations